TWIST1 regulates the activity of ubiquitin proteasome system via the miR-199/214 cluster in human end-stage dilated cardiomyopathy

International Journal of Cardiology

Volumn 168, Issue 2, 2013, Pages 1447-1452

  Baumgarten, Anna ^a,b   Bang, Claudia ^c   Tschirner, Anika ^a,b   Engelmann, Anke ^d   Adams, Volker ^d   Von Haehling, Stephan ^a,b   Doehner, Wolfram ^b   Pregla, Reinhard ^e   Anker, Markus S ^a,b   Blecharz, Kinga ^b   Meyer, Rudolf ^e   Hetzer, Roland ^e   Anker, Stefan D ^f   Thum, Thomas ^c,f   Springer, Jochen ^a,b,g  

^a DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^e DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^f IRCCS SAN RAFFAELE PISANA   (Italy)

^g UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Cardiomyopathy; DCM; MicroRNA; TWIST1; Ubiquitin proteasome system

Indexed keywords

MICRORNA; MICRORNA 199B; MICRORNA 214; PROTEIN UBE2G1; PROTEIN UBE2I; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR TWIST1; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL SIZE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; GENE CLUSTER; GENE EXPRESSION; GENE SILENCING; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; UPREGULATION;

CARDIOMYOPATHY; DCM; MICRORNA; TWIST1; UBIQUITIN PROTEASOME SYSTEM;

ADULT; ANIMALS; ANIMALS, NEWBORN; CARDIOMYOPATHY, DILATED; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NUCLEAR PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; TWIST TRANSCRIPTION FACTOR; UBIQUITIN;

EID: 84885330287     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.12.094     Document Type: Article

References (21)

1. Butler CR, Jugdutt Bi. The paradox of left ventricular assist device unloading and myocardial recovery In end-stage dilated cardiomyopathy: Implications for heart failure In the elderly. Heart Fail Rev 2012;17(4-5):615-33.
2. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme Inhibitor, ramipril, on cardiovascular events In high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-53.
3. Thum T, Gross C, Fiedler J, et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling In fibroblasts. Nature 2008;456:980-4.
4. Hartmann D, Thum T. MicroRNAs and vascular (dys)function. Vascul Pharmacol 2011;55:92-105.
5. Haghikia A, Missol-Kolka E, Tsikas D, et al. Signal transducer and activator of transcription 3-mediated regulation of miR-199a-5p links cardiomyocyte and endothelial cell function In the heart: a key role for ubiquitin-conjugating enzymes. Eur Heart J 2011;32:1287-97.
6. Sosic D, Richardson JA, Yu K, Ornitz DM, Olson EN. Twist regulates cytokine gene expression through a negative feedback loop that represses NF-kappaB activity. Cell 2003;112:169-80.
7. Hayashi M, Nimura K, Kashiwagi K, et al. Comparative roles of Twist-1 and Id1 In transcriptional regulation by BMP signaling. J Cell Sci 2007;120:1350-7.
8. Satoh K, Hamada S, Kimura K, et al. Up-regulation of MSX2 enhances the malignant phenotype and Is associated with twist 1 expression In human pancreatic cancer cells. Am J Pathol 2008;172:926-39.
9. Lee YB, Bantounas I, Lee DY, Phylactou L, Caldwell MA, Uney JB. Twist-1 regulates the miR-199a/214 cluster during development. Nucleic Acids Res 2009;37:123-8.
10. Otsuka K, Terasaki F, Shimomura H, et al. Enhanced expression of the ubiquitin-proteasome system In the myocardium from patients with dilated cardiomyopathy referred for left ventriculoplasty: an Immunohistochemical study with special reference to oxidative stress. Heart Vessels 2010;25: 474-84.
11. Springer J, Tschirner A, Hartman K, et al. Inhibition of xanthine oxidase reduces wasting and Improves outcome In a rat model of cancer cachexia. Int J Cancer 2012;131:2187-96.
12. Glass DJ. Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat Cell Biol 2003;5:87-90.
13. Portbury AL, Ronnebaum SM, Zungu M, Patterson C, Willis MS. Back to your heart: ubiquitin proteasome system-regulated signal transduction. J Mol Cell Cardiol 2012;52:526-37.
14. Klausner RD, Sitia R. Protein degradation In the endoplasmic reticulum. Cell 1990;62:611-4.
15. Galasso G, De Rosa R, Piscione F, et al. Myocardial expression of FOXO3a-Atrogin-1 pathway In human heart failure. Eur J Heart Fail 2010;12:1290-6.
16. Yazaki Y, Tsuchimochi H, Kurabayashi M, Kawana M, Kimata S. Distribution of cardiac myosin Isozymes In cardiomyopathy: Immunohistochemical and gene analysis. Jpn Circ J 1987;51:676-81.
17. LeWInter MM. Functional consequences of sarcomeric protein abnormalities In failing myocardium. Heart Fail Rev 2005;10:249-57.
18. Calalb MB, McKinsey TA, Newkirk S, Huynh K, Sucharov CC, Bristow MR. Increased phosphorylation-dependent nuclear export of class II histone deacetylases In failing human heart. Clin Transl Sci 2009;2:325-32.
19. Jen Y, Manova K, Benezra R. Expression patterns of Id1, Id2, and Id3 are highly related but distinct from that of Id4 during mouse embryogenesis. Dev Dyn 1996;207:235-52.
20. Vichalkovski A, Gresko E, Hess D, Restuccia DF, Hemmings BA. PKB/AKT phosphorylation of the transcription factor Twist-1 at Ser42 Inhibits p53 activity In response to DNA damage. Oncogene 2010;29:3554-65.
21. Xue G, Hemmings BA. Phosphorylation of basic helix-loop-helix transcription factor Twist In development and disease. Biochem Soc Trans 2012;40:90-3.